Rosen Law Firm reminds purchasers of GRAIL, Inc. common stock during the class period from May 13, 2025 to February 19, 2026 of the August 4, 2026 lead plaintiff deadline in a securities class action. If you purchased GRAIL common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The lawsuit alleges that defendants made materially false and misleading statements and concealed adverse facts about the NHS-Galleri trial, including that the trial period was insufficient to demonstrate a reduction in Stage III-IV cancers. Investors with losses exceeding $100,000 are encouraged to secure counsel before the deadline. More information is available at rosenlegal.com.
GRAIL, LLCSecurities class action lawsuit alleging false statements about NHS-Galleri trial, with lead plaintiff deadline approaching.